In addition, a person with sequencing results identifying different SARS-CoV-2 lineages regardless of the time since the previous specimen sequenced will be counted as a new surveillance case. reinfection) if they test positive for SARS-CoV-2 by a diagnostic test (i.e., molecular, antigen) and it has been greater than 90 days since the previous diagnostic test. A probable case is defined as a person who tests positive for SARS-CoV-2 specific antigen in a clinical or post-mortem specimen using a diagnostic test performed by a CLIA-certified provider*.Ī person will be counted as a new surveillance case (e.g. A confirmed case is defined as a person who tested positive for SARS-CoV-2 RNA in a clinical or post-mortem specimen using a diagnostic molecular amplification test (e.g., PCR, NAA) by a CLIA-certified provider* or identification of SARS-CoV-2 through genetic sequencing. Surveillance case definitions are not intended to be used by healthcare providers for making a clinical diagnosis or determining how to meet an individual patient’s health needs.įor cases identified beginning January 1, 2023, KDHE will utilize the updated CSTE/CDC surveillance case definition described in CSTE position statement 22-ID-01. Surveillance case definitions enable public health officials to classify and count cases consistently across reporting jurisdictions. A surveillance case definition is a set of uniform criteria developed by the Council of State and Territorial Epidemiologists (CSTE) and the Centers for Disease Control and Prevention (CDC) to define a disease for public health surveillance.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |